Tue, Dec 23, 2014, 12:34 AM EST - U.S. Markets open in 8 hrs 56 mins

Recent

% | $
Quotes you view appear here for quick access.

Markel Corp. Message Board

  • joeevani joeevani Dec 28, 2006 12:34 AM Flag

    Buy rating

    Markel "buy," target price raised

    Wednesday, December 27, 2006 1:26:39 AM ET
    Stifel Nicolaus

    NEW YORK, December 27 (newratings.com) - Analysts at Stifel Nicolaus & Company maintain their "buy" rating on Markel Corporation (MKL.NYS). The 12-month target price has been raised from $475 to $550.

    In a research published yesterday, the analysts mention that the company's long-term outlook remains favourable due to its well established underwriting discipline and favourable external rate environment. Markel�s book value per share has increased by about $14.40 quarter-to-date, excluding the impact of underwriting or investment income, the analysts say. The estimates have been revised to reflect the upcoming redemption of $107 million in Capital Securities on January 2, 2007, Stifel Nicolaus & Company adds. The EPS estimates for 2007 and 2008 being raised from $30.47 to $30.90 and from $29.78 to $30.36 respectively.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Market Matters looks as though it will increase my understanding of Markel. And yes, the annual reports will help as well. Thank you for the follow-up, Partner and Glider.

    • You can write to Markel Investors relations department to have the past annual reports. They are really worth the read.

      By the way, Glider, thanks for the info regarding "Market matters". I wasn't aware of it and it is interesting.

      If some people here want to read them, here is the link:

      http://www.markelintl.com/AboutMarkelInternational/Market+Matters.htm

      Cheers!

    • "The 12-month target price has been raised from $475 to $550".

      I don't trust people that have 12 month price target. They are wasting their time and brain power.

      I would say that one should not read at least 98% of analysts reports. Most of them do not help making sound long term investment decisions.

      • 2 Replies to partner24000
      • I�ve been investing in stocks for the past several years, and I�ve been trying to learn from my mistakes and successes as well as the mistakes and successes of others involved in the market. I try my best to make sense of company reports, but sometimes the language and related figures are beyond my grasp. So, I look for other opinions and suggestions about the companies of interest to me.

        For example, when gathering information about Markel Corp., I read a paper by A.M. Best Co. I also considered what was being said in publications such as the IBD, various newspapers, and indeed this message board.

        Now and then I note what analysts have to say, and even though I may discount an analyst�s opinion, I still consider the information that is being delivered, and I also think about the ways that this information may influence other investors. I posted (on this yahoo board) the piece about Markel by Stifel Nicolaus because it�s one part of what I�ve recently noticed in the news, and it�s one part of my learning process. My apologies to those of you who mostly dismiss such information.

      • I would say that one should not read at least 98% of analysts reports. Most of them do not help making sound long term investment decisions.

        You have that right! For instance, I have read that Buffet often invests in a company after an analyst downgrade reduces the market price.

 
MKL
687.25+1.80(+0.26%)Dec 22 4:02 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
ImmunoGen, Inc.
NASDAQMon, Dec 22, 2014 4:00 PM EST